Mach7 Technologies Limited
Mach7 Technologies Limited (M7T.AX) Stock Overview
Explore Mach7 Technologies Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
80.8M
P/E Ratio
-15.53
EPS (TTM)
$-0.02
ROE
-0.10%
M7T.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mach7 Technologies Limited (M7T.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.44.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.53 and a market capitalization of 80.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing solutions that include eUnity enterprise viewer, eUnity diagnostic viewer, and simplify image access. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.
Michael Lampron
120 Kimball Avenue, South Burlington, VT
2005